All > Prevention > Diabetes Type 2

Shared decision-making for diabetes prevention for Gestational Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Gestational Diabetes+2 MoreShared decision-making for diabetes prevention - Behavioral
Eligibility
18 - 54
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether shared decision making can help women with a history of gestational diabetes lose weight and adopt diabetes prevention strategies.

Eligible Conditions
  • Gestational Diabetes
  • Type 2 Diabetes
  • Pre-diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Recommended Diet
1
Insulin Detemir
1
Availability of contextual PGD at the visit

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 6, 12, and 24 months

12 months
Weight change
24 months
Weight Change
6 months
Uptake of DPP lifestyle program or metformin
Month 24
Health-related quality of life

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Recommended Diet
2
Insulin Detemir
1
Availability of contextual PGD at the visit

Trial Design

2 Treatment Groups

Usual Care
1 of 2
Shared decision-making with pharmacists
1 of 2

Active Control

Experimental Treatment

310 Total Participants · 2 Treatment Groups

Primary Treatment: Shared decision-making for diabetes prevention · No Placebo Group · N/A

Shared decision-making with pharmacists
Behavioral
Experimental Group · 1 Intervention: Shared decision-making for diabetes prevention · Intervention Types: Behavioral
Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6, 12, and 24 months

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,415 Previous Clinical Trials
6,762,957 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,148 Previous Clinical Trials
4,074,439 Total Patients Enrolled
Intermountain Health Care, Inc.OTHER
133 Previous Clinical Trials
1,790,289 Total Patients Enrolled
Kenrik Duru, MD,MSHSPrincipal InvestigatorUniversity of California, Los Angeles
Tannaz Moin, MD,MBA,MSHSPrincipal InvestigatorUniversity of California, Los Angeles

Eligibility Criteria

Age 18 - 54 · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
A patient who has received a visit from a provider or had labs done at UCLA or Intermountain Healthcare Systems within the past twelve months.
A person's history of prediabetes in the previous 36 months is defined by their most recent HbA1c result of 5.7-6.4%, their most recent FPG result of 100-125 mg/dL, or having prior diabetes diagnostic codes plus abnormal labs.
A BMI of 25 kg/m2 or above is considered overweight
Gestational diabetes mellitus (GDM) is a pregnancy complication characterized by high blood sugar levels

Who else is applying?

What state do they live in?
California100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
University of California, Los Angeles100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Most responsive sites:
  1. University of California, Los Angeles: < 48 hours
Typically responds via
Phone Call100.0%
Average response time
  • < 2 Days
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top